2-Butyl-4-Chloro-5-Formylimidazole (BCFI) CAS 83857-96-9 Losartan Potassium Intermediate Factory

Apejuwe kukuru:

Orukọ Kemikali: 2-Butyl-4-Chloro-5-Formylimidazole

CAS: 83857-96-9

Irisi: Imọlẹ Yellow si Yellow Crystalline Powder

Laarin ti Oogun Antihypertensive Potassium Losartan (CAS 124750-99-8)

Didara to gaju, iṣelọpọ Iṣowo

Inquiry: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Potasiomu Losartan ati Awọn agbedemeji ibatan
Losartan Potasiomu CAS 124750-99-8
2-Butyl-4-Chloro-5-Formylimidazole (BCFI) CAS 83857-96-9
Didara to gaju, iṣelọpọ Iṣowo

Kemikali Properties:

Orukọ Kemikali 2-Butyl-4-chloro-5-formylimidazole
Awọn itumọ ọrọ sisọ BCFI;2-Butyl-5-chloro-1H-imidazole-4-carboxaldehyde
Nọmba CAS 83857-96-9
NỌMBA CAT RF-PI319
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C8H11ClN2O
Òṣuwọn Molikula 186.64
iwuwo 1.240
Solubility Soluble ni kẹmika ati Chloroform;Die-die tiotuka ninu Omi
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Ina Yellow to Yellow Crystalline Powder
Idanimọ Gbọdọ ni ibamu si Iwọn Itọkasi
Ojuami Iyo 96.0 ~ 99.0 ℃ (tan.)
Akoonu Ọrinrin (KF) ≤0.50%
Imidazolol Ko ṣe awari
Valeronitile ≤0.15%
Idọti nikan ≤0.15%
Lapapọ aimọ ≤1.0%
Mimọ / Analysis Ọna ≥99.0% (nipasẹ HPLC)
Igbeyewo Standard Standard Enterprise
Lilo Agbedemeji ti Potasiomu Losartan (CAS 124750-99-8) Antihypertensive

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin.

Awọn anfani:

1

FAQ:

Ohun elo:

2-Butyl-4-chloro-5-formylimidazole (BCFI) (CAS 83857-96-9) jẹ agbedemeji ti Losartan Potassium (CAS 124750-99-8), antagonist olugba angiotensin II.Potasiomu Losartan jẹ iyọ potasiomu ti losartan pẹlu iṣẹ ṣiṣe antihypertensive, eyiti a lo ni pataki ni itọju ti titẹ ẹjẹ giga (haipatensonu) ati nephropathy dayabetik.O ṣiṣẹ nipa sisẹ awọn ohun elo ẹjẹ ki ẹjẹ le san diẹ sii ni irọrun.O tun munadoko lati ṣe iranlọwọ lati daabobo awọn kidinrin lati ibajẹ ti o fa nipasẹ àtọgbẹ ati dinku awọn eewu ti ọpọlọ ni awọn alaisan ti o ni haipatensonu ati imugboroja myocardial.Yato si, iwadi aipẹ ti daba pe losartan jẹ anfani lati yiyipada aiṣedeede ti o ni ibatan ọjọ-ori ni mimu titẹ ẹjẹ deede ati lilo agbara cellular lori mitochondria ati pe o le ṣee lo lati tọju hypertrophy ventricular osi.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa